Pseudobulbar Palsy
24
relevant articles (2 outcomes,
0 trials/studies)
found for this Disease
Description:
A syndrome characterized by DYSARTHRIA, dysphagia, dysphonia, impairment of voluntary movements of tongue and facial muscles, and emotional lability. This condition is caused by diseases that affect the motor fibers that travel from the cerebral cortex to the lower BRAIN STEM (i.e., corticobulbar tracts); including MULTIPLE SCLEROSIS; MOTOR NEURON DISEASE; and CEREBROVASCULAR DISORDERS. (From Adams et al., Principles of Neurology, 6th ed, p489)
Also Known As:
Pseudobulbar Mutism; Pseudobulbar Paralysis; Pseudobulbar Paresis; Pseudobulbar Syndrome; Bulbar Palsies, Spastic; Bulbar Palsy, Spastic; Dysarthrias, Pseudobulbar; Mutism, Pseudobulbar; Mutisms, Pseudobulbar; Palsies, Pseudobulbar; Palsies, Spastic Bulbar; Palsy, Pseudobulbar; Palsy, Spastic Bulbar; Paralyses, Pseudobulbar; Pareses, Pseudobulbar; Paresis, Pseudobulbar; Pseudobulbar Dysarthria; Pseudobulbar Dysarthrias; Pseudobulbar Mutisms; Pseudobulbar Palsies; Pseudobulbar Paralyses; Pseudobulbar Pareses; Pseudobulbar Syndromes; Spastic Bulbar Palsies; Syndrome, Pseudobulbar; Syndromes, Pseudobulbar; Dysarthria, Pseudobulbar; Paralysis, Pseudobulbar; Spastic Bulbar Palsy
Relationship Network
Disease Context: Research Results
Related Diseases
Experts
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Pseudobulbar Palsy:
| 1. | Levodopa (L Dopa)FDA LinkGeneric
07/20/2002
- " In patients with vascular PS (VP) there is generally no tremor and rigidity, but pseudobulbar palsy, dementia, gate disturbance, incontinency appears; L-dopa treatment is generally ineffective" 06/01/1996
- " RESULTS--The most frequent clinical features (occurring in at least 75% of the patients) were early postural instability and falls, vertical supranuclear palsy, akinetic-rigid predominant parkinsonian disorder characterised by symmetric bradykinesia and axial rigidity unrelieved by levodopa, pseudobulbar palsy, and frontal release signs" 01/01/1996
- " The following items, present in at least 80% of pathologically confirmed cases, can be considered as the most accurate clinical data for the diagnosis of PSP: non-familial parkinsonism, not improved by L-dopa therapy, with vertical voluntary gaze palsy; postural instability and falls; pseudobulbar palsy and dementia with frontal lobe-like syndrome; and a progressive course of less than 10 years" 10/01/1994
- " Furthermore, additional administration of L-dopa and droxidopa improved his pseudobulbar palsy, akinesia, and lack of initiative"
Order ALL the reference details at left...
|
| 2. | DroxidopaIBA
|
| 3. | TriadFDA Link
|
| 4. | Lithium Carbonate (Eskalith)FDA LinkGeneric
|
| 5. | Methotrexate (Mexate)FDA LinkGeneric
|
| 6. | ManganeseIBA
|
| 7. | Immunoglobulins (Immunoglobulin)IBA
|
| 8. | Glycine (Aminoacetic Acid)FDA LinkGeneric
|
| 9. | Cytidine Diphosphate Choline (Citicoline)IBA
|
| 10. | Cytarabine (Cytosar-U)FDA LinkGeneric
|
|
Therapies and Procedures
| 1. | Artificial Respiration (Mechanical Ventilation)
|
| 2. | Drug Therapy (Chemotherapy)
02/01/2003
- " RESULTS: Appropriate indications for PEG placement are 1) Esophageal obstruction (e.g., esophageal cancer), 2) Neurologic etiology of dysphagia without obstruction (e.g., status post cerebrovascular accident, pseudobulbar palsy), 3) Prolonged refusal to swallow without evidence of concomitant terminal illness (e.g., protracted pseudodementia due to severe depression), 4) Supplemental nutrition for patients undergoing chemotherapy or radiation therapy" 01/01/1980
- " The syndrome usually began several months after the initiation of chemotherapy with subtle personality changes followed by a progressive dementia, focal seizures, pseudobulbar palsy, spastic quadriparesis, and stupor"
Order ALL the reference details at left...
|
| 3. | Surgical Decompression
|
| 4. | Carotid Endarterectomy
|
| 5. | Liver Transplantation
|
|